Chief Executive Officer - Life Science / Cancer

To best treat cancer, we must first understand how the disease will develop. For five years, researchers at Oslo University Hospital, University of Oslo, University of Oxford and University College London have used deep learning and vast reserves of patient data to develop algorithms that provide the patients with a more precise prognosis to allow for better choices in treatment. The prognosis is calculated from a digitally transferred and stored scanned tumor sample – we call it “in silico pathology”. The excellent results have been published in international journals like Nature and Lancet. DoMore Diagnostics AS was founded in 2020 to commercialize the products that have been developed for the international Life Science market. The company has signed its first international pilot partnership and recently secured solid seed funding to allow for further development of its business. www.domorediagnostics.com
 

Job Description

The CEO‘s main focus area will be to develop DoMore Diagnostics in co-operation with the board of directors. We are looking for a self-motivated leader with experience from health, life science or medtech, that is hungry for a new challenge with substantial upside. You do love to sell ideas as well as products and you are trigged by the chance to build a new business while at the same time contributing to saving lives and health care resources. You will be recruiting and leading a small team. Together, you will be focusing on certification, marketing and sale of already developed and tested products as well as further development of new products and business models in the international life science market.

Primary responsibilities:

• Establish the company as an international vendor of in silico prognostic algorithms for cancer
• Build a strong, efficient team that will lift the product from current pilot stage to a “state of the art” test for cancer prognostication, including necessary certification for the different geographical markets
• Create a large footprint for DoMore Diagnostics´ in silico tests by building international partnerships with leading companies and institutions worldwide. 

Qualifications and skills:

• Higher Education: Master's degree (medicine, technical and/or commercial) or similar
• Experience from life science or medical technical devices, preferably within oncology. Experience with international medtech device regulations is an advantage
• Experience from development/commercialization with proven track record from internationalization and growth of early-phase companies
• Experience in sales management and B2B sales
• P&L responsibility experience
• Personell leadership experience
• International business experience
• Fluency in English is a must and preferably also fluency in Norwegian. Mastery of other important international languages is an advantage
• Highly self-motivated
• Excellent communication and presentation skills – able to communicate effectively with all stakeholders
• Our business is all about trust. You are trustworthy

DoMore Diagnostics offers you:

• To be part of an exciting journey in a high tech medical company that has a great potential for international growth
• A competitive salary will be offered the right candidate
• Large upside in the success of the company through stock options for a significant equity stake

If you have any questions regarding DoMore Diagnostics or the position, please contact our recruitment advisor in Gevir Group, Marianne Furru,  marianne@gevirgroup.no.
For more information and application see www.gevirgroup.no/stilling
 

 

--------------------------------------------------------
Vennligst referer til DN.no i din søknad.